{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,10]],"date-time":"2026-04-10T11:06:50Z","timestamp":1775819210727,"version":"3.50.1"},"reference-count":17,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"26","license":[{"start":{"date-parts":[[2022,6,30]],"date-time":"2022-06-30T00:00:00Z","timestamp":1656547200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"abstract":"<jats:p>The aim of this study was to determine the resistance status and to identify the point mutations conferring resistance to clarithromycin and fluoroquinolones among dyspeptic patients in Manisa, Turkey.<\/jats:p>\n          <jats:p>The study included a sample of 140 patients with an indication for upper gastrointestinal endoscopy randomly selected from 2100 dyspeptic patients attending to the Gastroenterology and Endoscopy Unit at Manisa Celal Bayar University Hafsa Sultan Hospital between April 2016 and May 2018. A commercially available GenoType Helico DR test was used to detect the presence of <jats:italic toggle=\"yes\">Helicobacter pylori<\/jats:italic> and mutations associated with resistance to clarithromycin and fluoroquinolones in biopsy specimens.<\/jats:p>\n          <jats:p>In total, 116 (82.9%) of 140 biopsies obtained from the same number of dyspeptic patients were positive for <jats:italic toggle=\"yes\">H pylori<\/jats:italic> and 82 (approximately 71%) of them harbored resistance mutations in 23SrRNA and\/or gyrA. Resistance to clarithromycin, levofloxacin, or both were detected in 43.1% (50\/116), 27.6% (32\/116), and 16\/116 (13.8%) of tested biopsies, respectively. The most common mutation conferring resistance to clarithromycin was A2147G (96%, 48\/50). Resistance to fluoroquinolones was frequently due to mutation in codon 91 and the most common mutation detected was D91G (34.4%). Heteroresistance patterns were observed in 48.0% (24\/50) of clarithromycin-resistant samples and 28.1% (9\/32) of levofloxacin-resistant samples.<\/jats:p>\n          <jats:p>The resistance rates and detected mutations in this study are in line with the country data. However, to achieve better <jats:italic toggle=\"yes\">H pylori<\/jats:italic> eradication and to prevent the spread of multidrug-resistant strains in Turkey, the molecular-based susceptibility tests should be considered routinely. Further studies are needed to determine the various mutations among resistant strains.<\/jats:p>","DOI":"10.1097\/md.0000000000029801","type":"journal-article","created":{"date-parts":[[2022,6,30]],"date-time":"2022-06-30T12:10:21Z","timestamp":1656591021000},"page":"e29801","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":3,"title":["Recent trends in the antibiotic resistance of Helicobacter pylori in patient with dyspepsia"],"prefix":"10.1097","volume":"101","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8077-2582","authenticated-orcid":false,"given":"Tahir","family":"Buran","sequence":"first","affiliation":[{"name":"Department of Gastroenterology, Manisa Celal Bayar University, Faculty of Medicine, Manisa, Turkey"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S\u00fcheyla","family":"S\u00fcr\u00fcc\u00fco\u011flu","sequence":"additional","affiliation":[{"name":"Department of Medical Microbiology, Manisa Celal Bayar University, Faculty of Medicine, Manisa, Turkey."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Semra","family":"Kurutepe","sequence":"additional","affiliation":[{"name":"Department of Medical Microbiology, Manisa Celal Bayar University, Faculty of Medicine, Manisa, Turkey."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H\u00f6r\u00fc","family":"Gazi","sequence":"additional","affiliation":[{"name":"Department of Medical Microbiology, Manisa Celal Bayar University, Faculty of Medicine, Manisa, Turkey."}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","published-online":{"date-parts":[[2022,6,30]]},"reference":[{"key":"R1-20250504","first-page":"87","article-title":"H. pylori treatment in Turkey: current status and rational treatment options.","volume":"7","author":"Kaplan","year":"2019","journal-title":"North Clin Istanb"},{"key":"R2-20250504","first-page":"1411","article-title":"Prevalence and pattern of antibiotic resistant strains of H. pylori infection in ASEAN.","volume":"19","author":"Vilaichone","year":"2018","journal-title":"Asian Pac J Cancer Prev"},{"key":"R3-20250504","first-page":"8481375","article-title":"H. pylori mutations conferring resistance to fluoroquinoloness and clarithromycin among dyspeptic patients attending a tertiary hospital, Tanzania.","volume":"1","author":"Jaka","year":"2019","journal-title":"Can J Gastroenterol Hepatol"},{"key":"R4-20250504","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1136\/gutjnl-2016-312288","article-title":"Management of H. pylori infection-the Maastricht V\/Florence consensus report.","volume":"66","author":"Malfertheiner","year":"2017","journal-title":"Gut"},{"key":"R5-20250504","doi-asserted-by":"crossref","first-page":"7587","DOI":"10.3748\/wjg.v22.i33.7587","article-title":"Detection of Helicobacter pylori resistance to clarithromycin and fluoroquinolones in Brazil: a national survey.","volume":"22","author":"Sanches","year":"2016","journal-title":"World J Gastroenterol"},{"key":"R6-20250504","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/j.ajg.2021.05.017","article-title":"Genotyping Helicobacter pylori antibiotic resistance and virulence-associated genes in patients with gastric cancer in Wenzhou, China.","volume":"22","author":"Li","year":"2021","journal-title":"Arab J Gastroenterol"},{"key":"R7-20250504","doi-asserted-by":"crossref","first-page":"2091","DOI":"10.3390\/jcm10102091","article-title":"What is new in Helicobacter pylori diagnosis. An overview.","volume":"10","author":"Dore","year":"2021","journal-title":"J Clin Med"},{"key":"R8-20250504","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1111\/hel.12272","article-title":"Prevalence of primary antimicrobial resistance of H. pylori in Turkey: a systematic review.","volume":"21","author":"Kocazeybek","year":"2016","journal-title":"Helicobacter"},{"key":"R9-20250504","first-page":"398","article-title":"Detection of H. pylori and antimicrobial resistance in gastric biopsy specimens","volume":"46","author":"Ca\u011fda\u015f","year":"2012","journal-title":"Mikrobiyol Bul"},{"key":"R10-20250504","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1590\/0037-8682-0027-2015","article-title":"Antimicrobial resistance of H. pylori strains to five antibiotics, including levofloxacin, in Northwestern Turkey.","volume":"48","author":"Caliskan","year":"2015","journal-title":"Rev Soc Bras Med Trop"},{"key":"R11-20250504","doi-asserted-by":"crossref","first-page":"e12581","DOI":"10.1111\/hel.12581","article-title":"H. pylori resistance to clarithromycin and fluoroquinoloness in a pediatric population in Turkey: a cross-sectional study.","volume":"24","author":"G\u00fcven","year":"2019","journal-title":"Helicobacter"},{"key":"R12-20250504","doi-asserted-by":"crossref","first-page":"1374","DOI":"10.1136\/gut.2003.022111","article-title":"H. pylori antibiotic resistance: prevalence, importance, and advances in testing.","volume":"53","author":"M\u00e9graud","year":"2004","journal-title":"Gut"},{"key":"R13-20250504","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1099\/jmm.0.000944","article-title":"Comparison of new and classical point mutations associated with clarithromycin resistance in H. pylori strains isolated from dyspeptic patients and their effects on phenotypic clarithromycin resistance.","volume":"68","author":"Kocazeybek","year":"2019","journal-title":"J Med Microbiol"},{"key":"R14-20250504","doi-asserted-by":"crossref","first-page":"1146","DOI":"10.1007\/s10620-017-4536-8","article-title":"Primary antibiotic resistance of H. pylori in China.","volume":"62","author":"Hu","year":"2017","journal-title":"Dig Dis Sci"},{"key":"R15-20250504","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1186\/s12866-016-0873-6","article-title":"Emerging H. pylori levofloxacin resistance and novel genetic mutation in Nepal.","volume":"16","author":"Miftahussurur","year":"2016","journal-title":"BMC Microbiol"},{"key":"R16-20250504","first-page":"1140","article-title":"Macrolide and fluoroquinolones resistance in H. pylori isolates: an experience at a tertiary care centre in Pakistan.","volume":"62","author":"Rajper","year":"2012","journal-title":"J Pak Med Assoc"},{"key":"R17-20250504","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1159\/000435949","article-title":"Prevalence of primary resistance of H. pylori to clarithromycin and levofloxacin in southern Spain.","volume":"92","author":"Navarro-Jarabo","year":"2015","journal-title":"Digestion"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000029801","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,4]],"date-time":"2025-05-04T04:10:15Z","timestamp":1746331815000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000029801"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,6,30]]},"references-count":17,"journal-issue":{"issue":"26","published-online":{"date-parts":[[2022]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000029801","relation":{},"ISSN":["1536-5964"],"issn-type":[{"value":"1536-5964","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,6,30]]}}}